Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Blood Advances|March 6, 2023
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control studyDaniel Tuyet Kristensen, Andreas Kisbye Øvlisen, Lasse Hjort Kyneb Jakobsen, et al.
Blood Advances|September 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasmsIsabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler, et al.
Frontiers in Immunology|March 13, 2023
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trialJacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite, et al.
American Journal of Hematology|July 31, 2013
World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experienceAnn Brinch Madelung, Henrik Bondo, Inger Stamp, et al.
Frontiers in Immunology|May 23, 2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell SuppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
Leukemia Research|July 6, 2013
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alphaThomas Stauffer Larsen, Katrine F Iversen, Esben Hansen, et al.
Acta Oncologica (Stockholm, Sweden)|September 1, 2023
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort studyLise Skovgaard Svingel, Sarah Friis Christensen, Anders Kjærsgaard, et al.
Blood|January 8, 2013
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopeniaSif Gudbrandsdottir, Henrik Sverre Birgens, Henrik Frederiksen, et al.
European Journal of Haematology|July 28, 2022
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort studySarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjaersgaard, et al.
Frontiers in Immunology|August 22, 2022
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
Pageof 16